Vitamin D supplementation for chronic liver diseases in adults.
The Cochrane database of systematic reviews(2021)
摘要
Given the high risk of bias and insufficient power of the included trials and the very low certainty of the available evidence, vitamin D supplementation versus placebo or no intervention may increase or reduce all-cause mortality, liver-related mortality, serious adverse events, or non-serious adverse events in adults with chronic liver diseases. There is a lack of data on liver-related morbidity and health-related quality of life. Further evidence on clinically important outcomes analysed in this review is needed.
更多查看译文
关键词
Administration,Oral,Calcitriol [administration & dosage],Cause of Death,Cholecalciferol [administration & dosage],Chronic Disease,Ergocalciferols [administration & dosage],Hepatitis C,Chronic [blood] [complications],Hydroxycholecalciferols [administration &,dosage],Liver Cirrhosis [blood] [complications],Liver Diseases [blood] [ complications] [mortality],Liver Transplantation,Nonalcoholic,Fatty Liver Disease [blood] [complications],Randomized Controlled Trials as Topic,vham/no ["administration & dosage],[analogs & derivatives],Vitamin D Deficiency [mortality] [*therapy],Vitamins [*administration & dosage],Female,Humans,Male,Middle Aged
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要